Abstract
Purpose
The glucose hydrogen breath test (GHBT) is commonly used as a noninvasive test to diagnose small bowel bacterial overgrowth (SBBO) but its validity has been questioned. Our aim was to evaluate the lactose-[13C]ureide breath test (LUBT) to diagnose SBBO and to compare it with the GHBT, using cultures of intestinal aspirates as a gold standard.
Methods
In 22 patients with suspected SBBO (14 male, age range 18–73 years) aspirates were taken from the region of the ligament of Treitz under sterile conditions and cultured for bacterial growth. More than 106 colony-forming units/mL fluid or the presence of colonic flora was defined as culture positive (c+). After oral intake of 50 g glucose and 2 g of lactose-[13C]ureide, end-expiratory breath samples were obtained up to 120 min. The 13C/12C ratio in breath CO2 was determined by isotope ratio-mass spectrometry and hydrogen concentration in breath was analyzed electrochemically.
Results
After analyzing receiver operating characteristic curves of the LUBT results, total label recovery of >0.88% at 120 min was considered positive. The test had a sensitivity of 66.7% and a specificity of 100% to predict c+. In the GHBT, an increase of the signal of ≥12 ppm from baseline was considered positive. The sensitivity and specificity of the test were 41.7 and 44.4%, respectively.
Conclusions
The new stable isotope-labeled LUBT has excellent specificity but suboptimal sensitivity. In contrast, the standard GHBT lacks both high sensitivity and specificity. The LUBT is superior to the GHBT for detecting SBBO.
Similar content being viewed by others
Abbreviations
- c.f.u.:
-
Colony forming units
- CO2 :
-
Carbon dioxide
- cPDR:
-
Cumulative percent dose recovery
- GHBT:
-
Glucose hydrogen breath test
- LUBT:
-
Lactose-[13C]ureide breath test
- ROC:
-
Receiver-operator characteristics
- SBBO:
-
Small bowel bacterial overgrowth
References
Drasar BS, Shiner M, McLeod GM. Studies on the intestinal flora. I. The bacterial flora of the gastrointestinal tract in healthy and achlorhydric persons. Gastroenterology. 1969;56:71–9.
Janda J, Abbott S. The enterobacteria. Washington: ASM Press; 2006.
Ziegler TR, Cole CR. Small bowel bacterial overgrowth in adults: a potential contributor to intestinal failure. Curr Gastroenterol Rep. 2007;9:463–7.
Gregg CR. Enteric bacterial flora and bacterial overgrowth syndrome. Semin Gastrointest Dis. 2002;13:200–9.
Sarna SK, Otterson MF. Small intestinal physiology and pathophysiology. Gastroenterol Clin North Am. 1989;18:375–404.
Kirsch M. Bacterial overgrowth. Am J Gastroenterol. 1990;85:231–7.
King CE, Toskes PP. Small intestine bacterial overgrowth. Gastroenterology. 1979;76:1035–55.
Lin HC. Small intestinal bacterial overgrowth: a framework for understanding irritable bowel syndrome. JAMA. 2004;292:852–8.
Singh VV, Toskes PP. Small bowel bacterial overgrowth: presentation, diagnosis, and treatment. Curr Gastroenterol Rep. 2003;5:365–72.
Anantharaju A, Klamut M. Small intestinal bacterial overgrowth: a possible risk factor for metabolic bone disease. Nutr Rev. 2003;61:132–5.
Donald IP, Kitchingmam G, Donald F, Kupfer RM. The diagnosis of small bowel bacterial overgrowth in elderly patients. J Am Geriatr Soc. 1992;40:692–6.
Elphick HL, Elphick DA, Sanders DS. Small bowel bacterial overgrowth. An underrecognized cause of malnutrition in older adults. Geriatrics. 2006;61:21–6.
Toskes PP. Bacterial overgrowth of the gastrointestinal tract. Adv Intern Med. 1993;38:387–407.
Simren M, Stotzer PO. Use and abuse of hydrogen breath tests. Gut. 2006;55:297–303.
Khoshini R, Dai SC, Lezcano S, Pimentel M. A systematic review of diagnostic tests for small intestinal bacterial overgrowth. Dig Dis Sci. 2008;53:1443–54.
Levitt MD. Production and excretion of hydrogen gas in man. N Engl J Med. 1969;281:122–7.
Nandi R, Sengupta S. Microbial production of hydrogen: an overview. Crit Rev Microbiol. 1998;24:61–84.
Gray C, Gest H. Biological formation of molecular hydrogen. Science. 1965;148:186–92.
Levitt MD, Donaldson RM. Use of respiratory hydrogen (H2) excretion to detect carbohydrate malabsorption. J Lab Clin Med. 1970;75:937–45.
Gilat T, Ben HH, Gelman-Malachi E, Terdiman R, Peled Y. Alterations of the colonic flora and their effect on the hydrogen breath test. Gut. 1978;19:602–5.
Solomons NW. The hydrogen breath test and gastrointestinal disorders. Compr Ther. 1981;7:7–15.
Ravich WJ, Bayless TM, Thomas M. Fructose: incomplete intestinal absorption in humans. Gastroenterology. 1983;84:26–9.
King CE, Toskes PP. Comparison of the 1-gram [14C]xylose, 10-gram lactulose-H2, and 80-gram glucose-H2 breath tests in patients with small intestine bacterial overgrowth. Gastroenterology. 1986;91:1447–51.
Kerlin P, Wong L. Breath hydrogen testing in bacterial overgrowth of the small intestine. Gastroenterology. 1988;95:982–8.
Corazza GR, Menozzi MG, Strocchi A, Rasciti L, Vaira D, Lecchini R, et al. The diagnosis of small bowel bacterial overgrowth. Reliability of jejunal culture and inadequacy of breath hydrogen testing. Gastroenterology. 1990;98:302–9.
Heine WE, Berthold HK, Klein PD. A novel stable isotope breath test: 13C-labeled glycosyl ureides used as noninvasive markers of intestinal transit time. Am J Gastroenterol. 1995;90:93–8.
He T, Priebe MG, Welling GW, Vonk RJ. Effect of lactose on oro-cecal transit in lactose digesters and maldigesters. Eur J Clin Invest. 2006;36:737–42.
De Preter V, Verbeke K. Evaluation of the necessity of induction for lactose-[15N, 15N]-ureide to study the colonic ammonia metabolism. Scand J Gastroenterol. 2006;41:396–400.
van den Driessche M, van Malderen N, Geypens B, Ghoos Y, Veereman-Wauters G. Lactose-[13C]ureide breath test: a new, noninvasive technique to determine orocecal transit time in children. J Pediatr Gastroenterol Nutr. 2000;31:433–8.
Ruemmele FM, Heine WE, Keller KM, Lentze MJ. Metabolism of glycosyl ureides by human intestinal brush border enzymes. Biochim Biophys Acta. 1997;1336:275–80.
Wutzke KD, Heine WE, Plath C, Leitzmann P, Radke M, Mohr C, et al. Evaluation of oro-coecal transit time: a comparison of the lactose-[13C, 15N]ureide 13CO2- and the lactulose H2-breath test in humans. Eur J Clin Nutr. 1997;51:11–9.
Geypens B, Bennink R, Peeters M, Evenepoel P, Mortelmans L, Maes B, et al. Validation of the lactose-[13C]ureide breath test for determination of orocecal transit time by scintigraphy. J Nucl Med. 1999;40:1451–5.
Jackson AA, Bundy R, Hounslow A, Murphy JL, Wootton SA. Metabolism of lactose-[13C]ureide and lactose-[15N, 15N]ureide in normal adults consuming a diet marginally adequate in protein. Clin Sci (Lond). 1999;97:547–55.
Morrison DJ, Dodson B, Preston T, Weaver LT. Gastrointestinal handling of glycosyl [13C]ureides. Eur J Clin Nutr. 2003;57:1017–24.
Murray, PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA, editors. Manual of clinical microbiology. 9th ed. Washington: ASM Press; 2007.
Klein PD. Clinical applications of 13CO2 measurements. Fed Proc. 1982;41:2698–701.
Lembcke B, Kirchhoff S, Caspary WF. Simplified methods of expiratory hydrogen (H2) analysis—clinical testing of two H2 breath test devices. Z Gastroenterol. 1983;21:545–9.
MacMahon M, Gibbons N, Mullins E, O’Moore RR, Keane CT, Walsh JB, et al. Are hydrogen breath tests valid in the elderly? Gerontology. 1996;42:40–5.
Flourie B, Turk J, Lemann M, Florent C, Colimon R, Rambaud JC. Breath hydrogen in bacterial overgrowth. Gastroenterology. 1989;96:1225.
Metz G, Gassull MA, Drasar BS, Jenkins DJ, Blendis LM. Breath-hydrogen test for small-intestinal bacterial colonisation. Lancet. 1976;1:668–9.
Taylor R, Avgerinos A, Taylor A, Hill M, Misiewicz J. Bacterial colonisation of the jejunum: an evaluation of five diagnostic tests. Gut. 1981;22:A442–3.
O’Connor M, Healy M, Kehely A, Keane C, O’Moore R, Weir D. H2- or 14C-breath tests in the diagnosis of small intestinal bacterial overgrowth? Gastroenetrology. 1987;92:1557.
Solomons NW, Schoeller DA, Wagonfeld JB, Ott D, Rosenberg IH, Klein PD. Application of a stable isotope (13C)-labeled glycocholate breath test to diagnosis of bacterial overgrowth and ileal dysfunction. J Lab Clin Med. 1977;90:431–9.
Dellert SF, Nowicki MJ, Farrell MK, Delente J, Heubi JE. The 13C-xylose breath test for the diagnosis of small bowel bacterial overgrowth in children. J Pediatr Gastroenterol Nutr. 1997;25:153–8.
Mohr C, Heine WE, Wutzke KD. Clostridium innocuum: a glucoseureide-splitting inhabitant of the human intestinal tract. Biochim Biophys Acta. 1999;1472:550–4.
Merry RJ, Smith RH, McAllan AB. Glycosyl ureides in ruminant nutrition. 3. In vivo studies on the metabolism of glycosyl ureides and corresponding mixtures of their free component molecules. Br J Nutr. 1982;48:305–18.
Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143:29–36.
King CE, Toskes PP, Spivey JC, Lorenz E, Welkos S. Detection of small intestine bacterial overgrowth by means of a 14C-d-xylose breath test. Gastroenterology. 1979;77:75–82.
Stark PL, Lee A. Clostridia isolated from the feces of infants during the first year of life. J Pediatr. 1982;100:362–5.
Drasar BS, Goddard P, Heaton S, Peach S, West B. Clostridia isolated from faeces. J Med Microbiol. 1976;9:63–71.
Acknowledgments
We would like to express our thanks to all patients participating in this study. The authors thank Drs. M. Neubrand, M. Schepke, and A. Al-Mubarak for their clinical assistance. We are indebted to Ms. A. Gey, Ms. U. Klanke, and Ms. A. Pfundstein for their excellent technical assistance.
Conflict of interest statement
No conflicts of interest exist.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Berthold, H.K., Schober, P., Scheurlen, C. et al. Use of the lactose-[13C]ureide breath test for diagnosis of small bowel bacterial overgrowth: comparison to the glucose hydrogen breath test. J Gastroenterol 44, 944–951 (2009). https://doi.org/10.1007/s00535-009-0097-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00535-009-0097-8